Dostarlimab-gxly

Generic Name: dostarlimab-gxly

Prescription Required

Manufactured by GLAXOSMITHKLINE LLC. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: DOSTARLIMAB-GXLY (500MG/10ML). Application: BLA761223.

Overview

Manufactured by GLAXOSMITHKLINE LLC. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: DOSTARLIMAB-GXLY (500MG/10ML). Application: BLA761223.

Dosage

Available as injectable for injection use.

Related Medications

Kali Muriaticum, Kali Phosphoricum, Kali Sulphuricum, Natrum Muriaticum, Natrum Phosphoricum, Natrum Sulphuricum, Calcarea Sulphurica, Calcarea Fluorica, Calcarea Phosphorica, Ferrum Phosphoricum, Magnesia Phosphorica, Silicea

kali muriaticum, kali phosphoricum, kali sulphuricum, natrum muriaticum, natrum phosphoricum, natrum sulphuricum, calcarea sulphurica, calcarea fluorica, calcarea phosphorica, ferrum phosphoricum, magnesia phosphorica, silicea

INDICATIONS: May temporarily relieve symptoms of impaired cellular function, such as constant thirst.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Florbetapir F 18

florbetapir f 18

Radioactive Diagnostic Agent [EPC]

11 DESCRIPTION 11.1 Drug Characteristics AMYVID (florbetapir F 18 injection) is a radioactive diagnostic drug for intravenous use. Chemically, florbetapir F 18 is (E)-4-(2-(6-(2-(2-(2[ 18 F] fluoroethoxy)ethoxy)ethoxy)pyridine-3-yl)vinyl)-N-methylbenzamine. The molecular weight is 359 and the structural formula is: AMYVID is a sterile, non-pyrogenic clear, colorless solution.

Dyclonine Hydrochloride

dyclonine hydrochloride

Description: DycloPro (Dyclonine Hydrochloride Topical Solution, USP, 0.5% and 1%) topical anesthetics contain a local anesthetic agent and are administered topically. See INDICATIONS for specific uses. DycloPro (Dyclonine Hydrochloride Topical Solution, USP, 0.5% and 1%) contain dyclonine HCl, which is chemically designated as 4’-butoxy-3-piperidinopropiophenone HCl.

Medical Disclaimer

This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.